Abiopharma

🔍 Dubugras Henrique Vasoncelos (Director)

Company: Expedia Group, Inc. (EXPE)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 49 shares of Stock Units (Derivative)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 48.73 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F3

Footnotes:

• F1: Stock units are convertible into common stock on a 1-for-1 basis.
• F2: Represents (as rounded) 48.725 stock units accrued under the Expedia Group, Inc. Non-Employee Director Deferred Compensation Plan (the "Plan") in lieu of director cash compensation for the quarter ended March 31, 2026.
• F3: Stock units under the Expedia Group, Inc. Non-Employee Director Deferred Compensation Plan are to be settled in shares of common stock of Expedia Group, Inc. after the reporting person's termination of services as a director.